Saint Mary's Regional Medical Center is a hospital at 93 Campus Avenue in Lewiston, Maine adjacent to Bates College. It is part of a complex of care facilities now operated by Covenant Health Systems, a Roman Catholic non-profit organization based in Massachusetts. The hospital has 233 beds.

There are 233 beds in Saint Mary's Regional Medical Center.

During the past decade, Saint Mary's Regional Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary's Regional Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary's Regional Medical Center" are "Adenocarcinoma of the Rectum" (1 trials), "Arthralgia" (1 trials), "Breast Adenocarcinoma" (1 trials), "Breast Cancer" (1 trials) and "Clear Cell Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Saint Mary's Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Mary's Regional Medical Center" are "Drug" (7 trials), "Other" (6 trials), "Biological" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Bevacizumab" (3 trials), "Quality-of-Life Assessment" (2 trials), "Anastrozole" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary's Regional Medical Center" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Mary's Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Saint Mary's Regional Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary's Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".